Future studies are warranted to delineate the detailed effects of BNP inhibition in kidney cGMP levels and acute renal failure in sepsis, as well as to clarify likely interactions with the arterial and venous vasculature, sympathetic nervous system, and the renin-angiotensin-aldosterone system. This evidence concerns the gene NPPB and Sepsis.